91 related articles for article (PubMed ID: 21335937)
1. Effect of Cordyceps sinensis on renal function of patients with chronic allograft nephropathy.
Zhang Z; Wang X; Zhang Y; Ye G
Urol Int; 2011; 86(3):298-301. PubMed ID: 21335937
[TBL] [Abstract][Full Text] [Related]
2. Clinical application of Cordyceps sinensis on immunosuppressive therapy in renal transplantation.
Li Y; Xue WJ; Tian PX; Ding XM; Yan H; Pan XM; Feng XS
Transplant Proc; 2009 Jun; 41(5):1565-9. PubMed ID: 19545680
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of chronic allograft nephropathy with combination of enalapril and bailing capsule].
Zhang ZH; Zhang WD; Yao K
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2008 Sep; 28(9):806-9. PubMed ID: 19065894
[TBL] [Abstract][Full Text] [Related]
4. [Role of transforming growth factor beta-1 gene polymorphisms in the development of chronic allograft nephropathy in renal transplant recipients].
Iñigo P; Lario S; Campistol JM; Bescós M; Campos B; Oppenheimer F
Nefrologia; 2003; 23(4):312-20. PubMed ID: 14558330
[TBL] [Abstract][Full Text] [Related]
5. Conversion from calcineurin inhibitor to sirolimus in pediatric chronic allograft nephropathy.
Falger JC; Mueller T; Arbeiter K; Boehm M; Regele H; Balzar E; Aufricht C
Pediatr Transplant; 2006 Jun; 10(4):474-8. PubMed ID: 16712606
[TBL] [Abstract][Full Text] [Related]
6. [Clinical observation on treatment of chronic allograft nephropathy with bailing capsule].
He XL; Chen JH; Wang YM
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2006 Feb; 26(2):102-5. PubMed ID: 16548346
[TBL] [Abstract][Full Text] [Related]
7. TGF-beta1 in chronic allograft nephropathy following renal transplantation.
Harris S; Coupes BM; Roberts SA; Roberts IS; Short CD; Brenchley PE
J Nephrol; 2007; 20(2):177-85. PubMed ID: 17514622
[TBL] [Abstract][Full Text] [Related]
8. Conversion to sirolimus for chronic allograft nephropathy and calcineurin inhibitor toxicity and the adverse effects of sirolimus after conversion.
Sayin B; Karakayali H; Colak T; Sevmis S; Pehlivan S; Demirhan B; Haberal M
Transplant Proc; 2009 Sep; 41(7):2789-93. PubMed ID: 19765436
[TBL] [Abstract][Full Text] [Related]
9. [Effects of urokinase on renal interstitial fibrosis and transforming growth factor-beta1 in the kidney of rats with chronic cyclosporine A nephropathy].
Wang Y; Tong JR; Luo ZM; He F; Ma L
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Dec; 29(12):2449-52. PubMed ID: 20034899
[TBL] [Abstract][Full Text] [Related]
10. Prediction of chronic renal allograft dysfunction from evaluations of TGFBeta1 and the renin-angiotensin system.
Yamada K; Hatakeyama E; Arita S; Sakamoto K; Kashiwabara H; Hamaguchi K
Clin Exp Nephrol; 2003 Sep; 7(3):238-42. PubMed ID: 14586721
[TBL] [Abstract][Full Text] [Related]
11. [Effects of Astragalus polysaccharides and Cordyceps sinensis mycelium mixture on the transforming growth factor-beta1 expression in chronic rejection of artery transplantation: experiment with rats].
Zhao S; Zhang WH; Fu YM; Cui HZ; Chi YM
Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(12):851-4. PubMed ID: 17565873
[TBL] [Abstract][Full Text] [Related]
12. The relationship between transforming growth factor beta1 expression and cold ischemia injury of rat donor kidney.
He W; Liu K; Ding H
Exp Mol Pathol; 2010 Feb; 88(1):206-9. PubMed ID: 19874817
[TBL] [Abstract][Full Text] [Related]
13. Molecular and clinical response to angiotensin II receptor antagonist in kidney transplant patients with chronic allograft nephropathy.
Mas VR; Alvarellos T; Maluf DG; Ferreira-Gonzalez A; Oliveros L; Maldonado RA; de Boccardo G
Transpl Int; 2004 Oct; 17(9):540-4. PubMed ID: 15349718
[TBL] [Abstract][Full Text] [Related]
14. [Effect of cytomegalovirus infection on long-term renal allograft function].
Tang B; Lv PY; Xu FY; Zheng KL; Liu D
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Aug; 29(8):1588-91. PubMed ID: 19726300
[TBL] [Abstract][Full Text] [Related]
15. [Association between transforming growth factor beta-1 gene polymorphism and chronic allograft nephropathy].
Li CJ; Yu LX; Xu J; Fu SJ; Deng WF; DU CF; Wang YB
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Apr; 27(4):535-7. PubMed ID: 17545053
[TBL] [Abstract][Full Text] [Related]
16. Impact of chronic allograft nephropathy and subsequent modifications of immunosuppressive therapy on late graft outcomes in renal transplantation.
Montagnino G; Banfi G; Campise MR; Passerini P; Aroldi A; Cesana BM; Ponticelli C
Nephrol Dial Transplant; 2004 Oct; 19(10):2622-9. PubMed ID: 15316096
[TBL] [Abstract][Full Text] [Related]
17. [Expressions of transforming growth factor-beta1 and collagen IV in renal tissues of patients with chronic allograft nephropathy].
Han CX; Yu LX; Xu J; Xie QX; Wang YB; Deng WF; Liu XY; Zeng JH
Di Yi Jun Yi Da Xue Xue Bao; 2005 May; 25(5):567-9. PubMed ID: 15897139
[TBL] [Abstract][Full Text] [Related]
18. The effect of different immunosuppressive regimens on TGF-beta1 expression in kidney transplant patients.
Matl I; Viklický O; Voska L; Lodererová A; Vítko S
Transpl Int; 2005 Jun; 18(6):668-71. PubMed ID: 15910291
[TBL] [Abstract][Full Text] [Related]
19. Management of chronic allograft dysfunction by switch over to rapamycin.
Sundaram V; Abraham G; Fathima N; Sundaram V; Reddy YN; Mathew M; Sathiah V
Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):37-42. PubMed ID: 20061690
[TBL] [Abstract][Full Text] [Related]
20. Conversion of ciclosporin A to tacrolimus in kidney transplant recipients with chronic allograft nephropathy.
Tang SC; Chan KW; Tang CS; Lam MF; Leung CY; Tse KC; Li CS; Ho YW; Tong MK; Lai KN; Chan TM;
Nephrol Dial Transplant; 2006 Nov; 21(11):3243-51. PubMed ID: 16877482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
